14.182 makale bulundu

Nörodejeneratif bozukluklarda nikotinik reseptörlerin rolünün genetik ve çevresel yönleri: Alzheimer hastalığı ve Parkinson hastalığına vurgu.

Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: emphasis on Alzheimer's disease and Parkinson's disease.

James JR, Nordberg A.

Behav Genet · 1995-03-01

DOI: 10.1007/bf02196924PMID: 7733856

Amiodaron kaynaklı parkinsonizm: bir vaka raporu ve patojenik tartışma.

Amiodarone-induced parkinsonism: a case report and pathogenetic discussion.

Dotti MT, Federico A.

Mov Disord · 1995-03-01

DOI: 10.1002/mds.870100223PMID: 7753074

Parkinson hastalığının genetik bir çalışması.

A genetic study of Parkinson's disease.

De Michele G, Filla A, Marconi R, Volpe G, D'Alessio A, Scala R, Ambrosio G, Campanella G.

J Neural Transm Suppl · 1995-01-01

PMID: 8748605

Epidemiological, genetic, pharmacological, kinesiological, nuclear medical (IBZM-SPECT), standard and functional MRI studies on Parkinson's disease and related disorders and economic evaluation of Parkinson's disease therapy--clinical projects in the BMFT-research program Munich: "Parkinson's disease and other basal ganglia disorders".

Oertel WH, Trenkwalder C, Gasser T, Schwarz J, Bucher SF, Eichhorn T, Pogarell O, Künig G, Arnold G, Bandmann O.

J Neural Transm Suppl · 1995-01-01

PMID: 8821069

Fluctuations in Parkinson's disease. Pathogenetic significance of levodopa's cerebral pharmacokinetics and pharmacodynamics.

Baas H, Harder S, Demisch L, Bürklin F, Stecker K, Fischer PA.

J Neural Transm Suppl · 1995-01-01

PMID: 8821072

Transplantation of cells genetically modified and direct intracerebral gene transfer with an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease.

Horellou P, Vigne E, Castel MN, Barnéoud P, Perricaudet M, Delaère P, Mallet J.

Restor Neurol Neurosci · 1995-01-01

DOI: 10.3233/rnn-1995-81214PMID: 21551808

Parkinson hastalığında genetik beklenti.

Genetic anticipation in Parkinson's disease.

Payami H, Bernard S, Larsen K, Kaye J, Nutt J.

Neurology · 1995-01-01

DOI: 10.1212/wnl.45.1.135PMID: 7824103

İdiyopatik Parkinson hastalığında sitokrom P450 2D6'nın genetik polimorfizmi ve yaygın Lewy vücut hastalığı.

Genetic polymorphism of cytochrome P450 2D6 in idiopathic Parkinson disease and diffuse Lewy body disease.

Bordet R, Broly F, Destee A, Libersa C.

Clin Neuropharmacol · 1994-10-01

DOI: 10.1097/00002826-199410000-00014PMID: 9316701

Amyotrofik lateral skleroz, demans ve Parkinson hastalığının ailesel birleşmesi: paylaşılan genetik duyarlılığın kanıtı.

Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson's disease: evidence of shared genetic susceptibility.

Majoor-Krakauer D, Ottman R, Johnson WG, Rowland LP.

Neurology · 1994-10-01

DOI: 10.1212/wnl.44.10.1872PMID: 7936240

Otozomal dominant parkinsonizmde genetik bağlantı çalışmaları: yedi aday genin değerlendirilmesi.

Genetic linkage studies in autosomal dominant parkinsonism: evaluation of seven candidate genes.

Gasser T, Wszolek ZK, Trofatter J, Ozelius L, Uitti RJ, Lee CS, Gusella J, Pfeiffer RF, Calne DB, Breakefield XO.

Ann Neurol · 1994-09-01

DOI: 10.1002/ana.410360310PMID: 7915897

Nörogenetik bozuklukların moleküler temeli ve teşhisi.

Molecular basis and diagnosis of neurogenetic disorders.

Müller U, Graeber MB, Haberhausen G, Köhler A.

J Neurol Sci · 1994-07-01

DOI: 10.1016/0022-510x(94)90318-2PMID: 7964863

Beyin kaynaklı nörotrofik faktör üretmek için genetik olarak tasarlanmış implante edilmiş fibroblastlar, sıçandaki dopaminerjik nöronlara 1-metil-4-fenilpiridiniyum toksisitesini önler.

Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat.

Frim DM, Uhler TA, Galpern WR, Beal MF, Breakefield XO, Isacson O.

Proc Natl Acad Sci U S A · 1994-05-01

DOI: 10.1073/pnas.91.11.5104PMID: 8197193